CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
87.11%
Total 13F principal
$92,017,002
Principal change
-$202,525,077
Total reported market value
$79,654,678
Number of holders
11
Value change
-$181,154,892
Number of buys
1
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q3 2019

As of 30 Sep 2019, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $92,017,002 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Allianz Asset Management GmbH, FMR LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, BNP PARIBAS ASSET MANAGEMENT Holding S.A., MACKAY SHIELDS LLC, GABELLI & Co INVESTMENT ADVISERS, INC., Federation des caisses Desjardins du Quebec, UBS Group AG, and ROYAL BANK OF CANADA. This page lists 11 institutional bondholders reporting positions for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.